Bio

Steven Ducommun is a partner with the firm's Corporate practice. He concentrates his practice in corporate and securities law with an emphasis on mergers and acquisitions, strategic alliances, commercial contracting and financings. He regularly represents companies in a number of industries, including health care, biotechnology, food and procurement, cleantech, pharmaceutical, medical devices, agribusiness, metals and information technology. Steve counsels clients on formation issues, research and development arrangements and with respect to numerous commercial matters, including technology commercialization, licensing, manufacturing and distribution. A major focus of his practice is the acquisition and sale of companies, frequently representing companies that are serial acquirers. He frequently acts as primary outside counsel to a number of companies ranging from mature companies in a number of industries, as well as to a number of early and growth stage companies in the health care, life sciences and cleantech industries. In addition, he has particular experience in representing companies entering into joint ventures with health care providers, such as physicians, in diverse areas including physical therapy, oncology and ambulatory surgery, including the structuring and compliance aspects of such arrangements. Steve is a frequent speaker on such topics as commercializing life sciences and cleantech innovations, strategic alliances, and forming and financing start-up and emerging companies.